Oxford Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Oxford Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-53,943	Closed	-$212K	–	1760
2019 Q4	$212K	Sell	53,943 -13,739	-20%	-$81.1K	0.01%	1540
2019 Q3	$596K	Buy	67,682 +21,880	+48%	+$207K	0.01%	1193
2019 Q2	$424K	Buy	+45,802	New	+$345K	0.01%	1336
2019 Q1	–	Sell	-15,173	Closed	-$143K	–	2239
2018 Q4	$143K	Buy	+15,173	New	+$228K	﹤0.01%	1606
2016 Q3	–	Sell	-40,385	Closed	-$646K	–	983
2016 Q2	$646K	Sell	40,385 -31,162	-44%	-$559K	0.02%	555
2016 Q1	$1.5M	Buy	+71,547	New	+$1.28M	0.04%	423

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's LJPC Position: Q1 2020 in Review

Oxford Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2020, closing a stake of 53,943 shares — an estimated $212K sold.

Oxford Asset Management first reported a position in LJPC in Q1 2016 and held it in 6 quarters. The position peaked at $1.5M in Q1 2016. 73 funds tracked by Wall St. Rank hold LJPC as of Q1 2020.

Oxford Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 53,943 La Jolla Pharmaceutical Company shares in Q1 2020, an estimated $212K.
Oxford Asset Management first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 6 quarters.
Oxford Asset Management's La Jolla Pharmaceutical Company position peaked at $1.5M in Q1 2016.
73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.